Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

Bullboard (TSXV:SBM)

View:
Prev ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... Next
Comment by lscfaon Mar 23, 2023 10:19am

RE:Debenture issuance

genius move..... "We at Sirona Biochem deliberately opted for a higher royalty payment percentage instead of a larger upfront pay,ent. The board and the management made a unanimous decision to ...more  
133
Discussion
Comment by lscfaon Mar 23, 2023 9:59am

RE:Debenture issuance

Why not do a financing after the clinical results when the stock price may be higher?  Bozo mgmt.
74
Discussion
Post by SleepyHowardon Mar 23, 2023 9:41am

What a ceo

Next pain in the a.. .  Where is the benefit for the shareholder  when the ceo is filling his pocket
94
Post by Pareto8020on Mar 23, 2023 9:36am

Debenture issuance

Well looks like we found out how they are going to keep the doors open -at least Howie is putting his money where his mouth is for $500k.  So he probably just took his salary from SBM for the ...more  
274
Discussion
Post by SleepyHowardon Mar 22, 2023 5:59am

Anti aging

Excited to see the anti aging results.  This week? 
157
Comment by MirrorWorldManon Mar 20, 2023 11:38am

RE:RE:Company sale

My experience for Venture companies that are spinning in the mud and then bought suggest that purchase price is a small multiple of its recent history, not a factor of shareholder perceived worth ...more  
99
Discussion
Comment by Pandoraon Mar 20, 2023 10:33am

RE:Spring has Sprung

Spring has sprung, the grass is ris, I wonder where all, The flowers is.
52
Discussion
Post by Pareto8020on Mar 20, 2023 10:10am

Spring has Sprung

Fingers crossed that long eared varmit brings us more than chocolate - a nice off the chart clinical trial result or a pet deal would be welcomed. Heck I would even take a new CEO before the Summer & ...more  
214
Discussion
Comment by emerald03on Mar 18, 2023 9:00pm

RE:RE:Company sale

Depends on anti aging results in next few weeks. If good, an auction later in the year would probably fetch over a dollar fifty cents   from Abbvie at minimum as that is their interest with ...more  
112
Discussion
Comment by emerald03on Mar 18, 2023 8:52pm

RE:RE:Company sale

Sure, why not use any good results to put the company up for sale? If they do the tfc1067 way, we are talking 2 years to negotiate the deal then 2 years to get formulation to market - that will finish ...more  
79
Discussion
Comment by forhandlarenon Mar 18, 2023 5:04pm

RE:Company sale

The anti-aging represent tremendous value assuming the clinical trial was successful. I think it was finished last Friday and now subject to evaluation. If they would tune the anti-viral right it ...more  
137
Discussion
Comment by BradlTheGermanon Mar 18, 2023 3:46pm

RE:Company sale

So who is willing to buy this company and for what price? What would be a fair value?  I doubt that there is an interested company  right now. 
69
Discussion
Prev ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities